SCHEMBL3762799

SCHEMBL3762799

Cc1ccc(S(=O)(=O)Nc2ccccc2)c(F)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA9 Q16790 1/20 0.56
PTK2B Q14289 1/20 0.52
ALDH1A1 P00352 3/20 0.51
MAPT P10636 2/20 0.51
POLB P06746 1/20 0.51
HPGD P15428 1/20 0.51
ALOX12 P18054 1/20 0.51
GFER P55789 1/20 0.51
KMT2A Q03164 3/20 0.50
LMNA P02545 2/20 0.50
MEN1 O00255 2/20 0.50
GAA P10253 2/20 0.50
RORC P51449 1/20 0.49
TET2 Q6N021 1/20 0.48
TSHR P16473 1/20 0.48
IDH1 O75874 2/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17609451 0.83 PTK2B (0.55) PTK2BALDH1A1MAPTPOLBLMNA
SCHEMBL3771893 0.81 CCR2 (0.60) PTK2BTET2ALPL
SCHEMBL7837492 0.81 KMT2A (0.56) PTK2BALDH1A1MAPTPOLBKMT2A
SCHEMBL3769067 0.81 CA12 (0.56) CA12CA1CA2CA9ALDH1A1
SCHEMBL29688324 0.81 CA12 (0.56) CA12CA1CA2CA9ALDH1A1
SCHEMBL23536076 0.80 ALDH1A1 (0.69) CA12CA1CA2CA9ALDH1A1
SCHEMBL29931926 0.80 ALDH1A1 (0.69) CA12CA1CA2CA9ALDH1A1
SCHEMBL7163015 0.79 ALDH1A1 (0.68) PTK2BALDH1A1MAPTPOLBGFER
SCHEMBL15880563 0.78 CA1 (0.52) CA1CA2ALDH1A1MAPTPOLB
SCHEMBL17342883 0.78 GAA (0.48) ALDH1A1MAPTPOLBHPGDALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100311741-A1 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents INHIBOX LTD. (GB) 2010-12-09 US disclosed
US-20100311741-A1 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents INHIBOX LTD. (GB) 2010-12-09 US disclosed
US-20100311741-A1 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents INHIBOX LTD. (GB) 2010-12-09 US disclosed
WO-2008142376-A1 BICYCLOSULFONYL ACID (BCSA) COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS INHIBOX LTD. (GB) 2008-11-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311741-A1 Bicyclosulfonyl Acid (BCSA) Compounds and Their Use as Therapeutic Agents TNF, CS, COASY CA12 2435/4885CA1 1019/4885CA2 3303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.